Introduction
Members of the Ras superfamily of small GTP-binding proteins have important regulatory roles in diverse cellular functions, including mitogenesis, cytoskeletal rearrangements, transcytosis, and motility (reviewed by Bokoch and Der, 1993; Bourne et al., 1990; Downward, 1990; Hall, 1993) . Whereas the Rab and Arf subfamilies control vesicular protein trafficking (reviewed by Ferro-Novick and Jehn, 1994; Rothman, 1994) , the Ras and Rho subfamilies function in signal transduction. The Ras proteins link growth factor receptor activation to gene regulation through mitogen-activated protein kinase (MAPK) cascades that eventually lead to phosphorylation of specific transcription factors (reviewed by Marshall, 1995) . Growth factor receptor activation results in recruitment of the nucleotide exchange factor Sos to the plasma membrane, where it activates Ras by catalyzing the exchange of GDP by GTP (Aronheim et al., 1994; Buday and Downward, 1993) , The Ras-GTP form recruits the serine/threonine kinase Raf to the plasma membrane, thereby permitting its activation by signals yet to be identified (Leevers et al., 1994; Stokoe et al., 1994) . Once activated, Raf phosphorylates and activates the dual specificity kinases MEK1 and MEK2, whose substrates are the extracellular signalregulated ERK1 and ERK2 MAPKs (reviewed by Cobb and Goldsmith, 1995; Marshall, 1995) . The activated ERKs phosphorylate several important cytoplasmic substrates and also translocate to the nucleus, where they phosphorylate transcription factors leading to immediate-early gene induction (reviewed by Marshall, 1995; Hill and Treisman, 1995) . The use of constitutively activated and catalytically inactive MEK1 mutants has offered the view that activation of the ERK cascade is both necessary and sufficient for oncogenic transformation and presumably for a mitogenic response (Cowley et al., 1994; Mansour et al., 1994) . Indeed, an effector domain mutant of oncogenic HaRas(V12) that cannot bind Raf-1 and activate the ERK cascade, Ha-Ras(V12;E37G), is nontransforming (White et al., 1995) . However, another effector domain mutant, Ha-Ras(V12;T35S), which is fully capable of binding Raf and stimulating ERK activity, is compromised in its transforming activity, suggesting that additional Ha-Ras effectors contribute to cell transformation and presumably mitogenesis (White et al., 1995) . The identity of these effectors is not clear.
Recently, downstream mediators linking Ras activation to nuclear events were identified. Ras activation was shown to play a critical role in activation of members of the MAPK group, the c-Jun N-terminal kinases (JNKs) (also known as stress-activated protein kinases [SAPKs] ; D6ri-jard et al., 1994; Kyriakis et al., 1994) , in response to growth factors (Minden et al., 1994) . Like the ERKs, the activated JNKs translocate to the nucleus (F. Dolfi and M. K., unpublished data), where they phosphorylate transcription factors such as c-Jun (Hibi et al., 1993; Suet al., 1994) and ATF2 (Gupta et al., 1995) . Although Ha-Ras function is essential for JNK activation by growth factors (but not by cytokines, such as tumor necrosis factor a [TNF~]), oncogenically activated Ha-Ras leads only to partial JNK activation (Minden et al., 1994) . By contrast, HaRas is sufficient for full ERK activation (de Vries-Smits et al., 1992; Robbins et al., 1992; Thomas et al., 1992; Wood et al., 1992) . Another difference between the JNK and ERK cascades is that Raf is not directly involved in JNK activation (Minden et al., 1994) . Instead, the JNK cascade is strongly activated by the MAPKKK MEKK1, which, unless overexpressed, does not lead to ERK activation (Minden et al., 1994; Yah et al., 1994) . Although MEKK1 activity is stimulated by growth factors in a Ras-dependent manner (Lange-Carter et al., 1993; Lange-Carter and Johnson, 1994) , the mechanism of its activation is not clear. In yeast, activation of an MEKK1 homolog, STE11, by the pheromone receptor appears to involve activation of another protein kinase, STE20 (reviewed by Herskowitz, 1995) .
Members of the Rho subfamily, although less extensively studied than the Ras subfamily, also play critical roles in growth factor signaling through regulation of the actin cytoskeleton (reviewed by Ridley, 1994 (B) NIH 3T3 cells were transfected as described in (A) using 0.5 ~g of each of the indicated small GTPase expression vectors or 0.2 p.g of Cdc42Hs(V12) expression vector. Total DNA concentration was kept constant using pSRa. Kinase activities were determined as described above. These experiments were repeated at least three times with similar results.
(C) HeLa cell lysates from (A) were analyzed by immunoblotting for expression of Myc-tagged Racl(V12), RhoA(Vt 4), and Cdc42Hs(V12). " (D) HeLa cells were transfected with 1 I~g of pSRa-HA-JNK1 together with either empty expression vector (lane C), Rac1(V12), or Cdc42Hs(V12) expression vectors. Cells transfected with HA-JNK1 and empty vector were treated with or without EGF (15 ng/ml) for 15 min. JNK activity was measured as described in (A). The fold stimulation over unstimulated cells, as quantitated by phosphorimager, is presented. These experiments were repeated three times with similar results. (E) RatlA cells stably expressing Racl(V12) or Cdc42Hs(V12) and parental cells (Con) were assayed for endogenous JNK or ERK activity by immunocomplex kinase assays with GST-c-Jun (G-cJ) or MBP, respectively, as substrates. Parental cells were treated ~th or without EGF (15 ng/ml for 10 rain). JNK1 expression level was measured by immunoblotting. These experiments were repeated twice with similar results. (F) HeLa cells were transfected with pCMV5-M2-p38 (1 p.g) together with empty expression vector (Con) or the indicated expression vectors, p38 activity was determined by immunocomplex kinase assay using GST-ATF2A as substrate. A sample of each immunoprecipitate was analyzed for its content of M2-p38 by immunoblotting. This experiment was repeated twice with similar results. of cortical actin fibers , whereas Rho controls formation of stress fibers . Rac is also involved in activation of the NADPH oxidase complex in neutrophils (reviewed by Segal and Abo, 1993) . Recently, another member of this subfamily, human Cdc42 (Cdc42Hs), was found to be involved in filopodia formation (Kozma et al., 1995; Nobes and Hall, 1995) . Like the Ras proteins, the Rho-like proteins are believed to be activated in response to growth factors and polypeptide hormones (Hall, 1993; Nobes and Hall, 1994; Ridley, 1994) . With the exception of NADPH oxidase activation, the Rho-like proteins were hitherto thought to function exclusively in the regulation of cell morphology, an evolutionary conserved role that is also displayed by Saccharomyces cerevisiae Cdc42 (Cdc42Sc), which regulates bud site selection and cell polarity (Adams et al., 1990) . Both Racl and Cdc42Hs in their GTP-Ioaded states can bind to the p21-activated serine/threonine kinase PAK65 and stimulate its autophosphorylation activity (Manser et al., 1994; Martin et al., 1995) . Although PAK65 is a STE20 homolog, its substrates or biological functions remain unknown. Recently, Racl was found to be an important mediator of oncogenic transformation by Ha-Ras and capable of cooperating with a membrane-targeted form of Raf (Raf-CAAX; Qiu et al., 1995) . Here we describe a role for Rac and Cdc42Hs in signal transduction to the nucleus. Constitutively activated Racl/Rac2 and Cdc42Hs, but not RhoA, are efficient and specific activators of the JNK cascade, leading to increased c-Jun transcriptional activity. These proteins are also efficient activators of another MAPK, p38/ Mpk2 (Han et al., 1994; Lee et al., 1994; Rouse et al., 1994) , but they do not stimulate ERK activity. A dominant negative Racl mutant, Racl(N 17), attenuated JNK activation by growth factors, v-Src, and Ha-Ras. We propose that Racl and (possibly) Cdc42Hs are important intermediates to the J NK and p38 activation cascades and serve to coordinate inputs from growth factor receptors and other extracellular stimuli.
Results

Activation of JNK and p38 but Not ERK by Activated Rac Proteins
To examine whether other members of the Ras superfamily, in addition to Ha-Ras, can stimulate mammalian MAPK cascades, we used expression vectors encoding constitutively activated versions of Racl, Rac2, RhoA, and Cdc42Hs. These GTPases were activated either by substitution of G12 or its equivalent (G14 in RhoA) by a valine residue Kozma et al., 1995) or Q61 by a leucine residue . To test the effects on JNK and ERK activity, we cotransfected the different GTPase expression vectors with plasmids encoding hemagglutinin (HA) epitope-tagged versions of JNK1 and ERK2 (Minden et al., 1994) . After 48 hr, the transiently expressed HA-JNK1 and HA-ERK were isolated by immunoprecipitation, their activities were determined by phosphorylation of either gluthionine S-transferase (GST)-c-Jun(1-79) or myelin basic protein (MBP), respectively, and their expression levels were determined by immunoblotting. Racl, Rac2, and Cdc42Hs were efficient JNK1 activators in both HeLa ( Figure 1A ) and NIH 3T3 (Figure 1 B) cells. In both cell types, Rac and Cdc42Hs were more effective JNK activators than Ha-Ras(L61). In contrast, RhoA(V14) did not stimulate JNK activity, despite its efficient expression ( Figure 1C) . None of the Rho-'like proteins had a considerable effect on ERK2 activity, which was strongly stimulated by Ha-Ras(L61) ( Figures 1A and  1B) . Racl(N17), which, like H a-Ras(N 17), is inactive owing to its higher affinity toward GDP (Feig and Cooper, 1988; , did not activate JNK and, in fact, reduced its basal activity. The stimulation of JNK activity by either Racl(V12) or Cdc42Hs(V12) was as efficient as its stimulation by either epidermal growth factor (EGF) (Figure 1D ) or TNFa (data not shown; see, however, Figure  4 ) treatment of the same cells. Titration experiments indicated that near-maximal JNK activation was observed with either 50 or 200 ng of the Cdc42Hs(V12) or Rac1(V12) expression vectors, respectively. At these levels, their expression did not exceed the endogenous level of their wildtype counterparts by more than 6-fold (Cdc42Hs) or 1.5-fold (Racl).
We measured JNK activity (both JNK1 and JNK2) in RatlA cells stably expressing Racl (V12) or Cdc42Hs(V12). In both cases, it was elevated in comparison with the unstimulated parental cells ( Figure 1E ). The extent of JNK activation was similar to its response to EGF, which, owing to a higher basal JNK activity in these cells, was lower than the usual 10-to 20-fold seen in other cell lines. Even in these stable transformants, Racl (V12) and Cdc42Hs(V12) did not stimulate ERK activity. Immunoblot analysis indicated that the levels of Rac1(V12) and Cdc42Hs(V12) expression in these stably transfected clones were no more than 2-to 3-fold higher than the levels of their endogenous wild-type counterparts (data not shown). As shown below, Rac and Cdc42Hs also stimulate JNK activity in COS-1 cells (see Figure 7) .
Recently, a member of the MEK subfamily, SEKI/ MKK4/JNKK, was identified as an activator of both the JNKs and p38/Mpk2 (D~rijard et al., 1995; Lin et al., 1995) . Another member of the MEK group, MKK3, is a specific p38 activator (Ddrijard et ai., 1995) . To examine the effect of Rac1(V12) and Rac2(L61) on p38 activity, we cotransfected them with an M2-p38 expression vector. Immunocomplex kinase assays using GST-ATF2 as a substrate indicated that both Racl and Rac2 were potent p38 activators, leading to more efficient activation than MKK3 (Figure 1F ).
Functional Relationships among the Small G Proteins
Ha-Ras(L61)-induced ruffling is inhibited by Rac1(N17) . To examine whether Racl(N17) also exhibits a dominant negative effect on JNK activation by Ha-Ras, we cotransfected the HA-JNK1 and Ha-Ras(L61) expression vector with or without the Rac1(N17) vector. Expression of Racl(N17) led to almost complete inhibition of JNK activation by Ha-Ras(L61) (Figure 2A ). No effect of Rac1(N17) on Ha-Ras (L61) expression was detected (data not shown). On the other hand, Ha-Ras(N17) in amounts sufficient for nearly complete inhibition of JNK activation by EGF (Minden et al., 1994 ; see below) had only a minor effect on JNK activation by Rac2(L61) ( Figure  2A ). These results suggest that Rac acts downstream of Ha-Ras in the pathway leading to JNK activation.
Next, we examined the relationships between Racl/ Rac2 and Cdc42Hs. We found that Rac1(N17) partially inhibited the activation of HA-JNK1 by the cotransfected Cdc42Hs(V12) expression vector ( Figure 2B ), but not by Rac1(V12) (data not shown). Cdc42Hs(N 17) partially inhibited HA-JNK1 activation by ct~transfected Rac2(L61), but somewhat less efficiently than Rac1(N17) inhibited the stimulation by Cdc42Hs(V12). HA-JNK1 activation by Cdc42Hs(V12) was completely inhibited by cotransfection of a truncation mutant of human PAK65. This mutant, PAKR(1-225), contains the regulatory domain that binds to either Racl • GTP or Cdc42Hs. GTP but lacks the catalytic domain (Martin et al., 1995; A. A., unpublished data) . Cotransfection of a RhoA(N19) mutant had only a marginal effect on JNK activation by Rac2(L61) ( Figure 2B ). Thus, while RhoA is not involved in JNK activation, we were not able to draw clear conclusions whether Cdc42Hs acts upstream of Racl and Rac2, as previously suggested by examination of their morphological effects (Nobes and Hall, 1995; Kozma et al., 1995) . However, the effect of Cdc42Hs(N17) on Racl-induced lamellipodia formation has not been examined.
Although Ha-Ras activity is necessary for JNK activation in response to growth factors, Ha-Ras(L61) is considerably less effective than EGF in activating JNK (Minden et al., 1994) . We therefore examined whether Ha-Ras(L61) and Rac1(V12) can act additively to stimulate J N K activity. We Even the lower dose of Ha-Ras(N17) is sufficient to block completely growth factor activation of JNK (data not shown). JNK activity was measured by immunocomplex kinase assays, and HA-JNK expression was measured by immunoblotting. After quantitation with a phosphorimager, the highest level of JNK activity was given an arbjtary value of 100%, and the other activities are shown relative to this value. G-c J, GST-c-Jun.
(B) HeLa cells were transfected with 0.1 p,g of pSRa-HA-JNK1 and 1 #g of Rac2(L61) or Cdc42HS(V12) in the absence or presence of 0.5 and 1 p.g of Rac1(N17), 1 p,g of PAKR, 0.5 and 1 p,g of Cdc42Hs(N17), or 0.5 and 1 p,g of RhoA(N19) expression vectors, as indicated. HA-JNK1 activity was determined and calculated as described above. All of these experiments were repeated at least twice with similar results.
found that cotransfection of the HA-JNK1 expression vector with a saturating amount of a Ha-Ras(L61) plasmid and a suboptimal amount of a Rac1(V12) expression vector resulted in very efficient JNK activation that exceeded the sum of the two individual responses (Figure 3 ). Wild-type Racl did not potentiate the response to Ha-Ras(L61) (data not shown).
Riicl Acts Downstream of Tyrosine Kinases
We examined the effects of Rac1(N17) on JNK activation by either EGF or TNFa. Cotransfection with the Racl (N 17) plasmid partially inhibited the activation of HA-JNK1 by EGF, but hardly affected its response to TNFa (Figure 4) . 
JNK Activation by the Dbl Oncogene Product
Members of the Rho subfamily are activated by a variety of exchange factors that contain Dbl homology domains (reviewed by Ridley, 1994) . It remains to be determined which exchange factor is specific to each of the Rho-like proteins in vivo. We examined the effects of the Dbl onco- (B) HeLa cells were transfected as described above, except that HA-ERK2 was used instead of HA-JNK1. Cells transfected with HA-ERK2 and empty vector were treated with or without EGF (15 ng/ml for 15 rain). ERK activity was measured by immunocomplex kinase assays using MBP as substrate.
protein (Eva and Aaronson, 1985) on JNK activity. In vitro, Dbl acts as an exchange factor for Cdc42Hs and RhoA, but not Racl (Hart et al., 1991 (Hart et al., , 1994 . Cotransfection with a Dbl expression vector resulted in efficient JNK activation ( Figure 6A ). To determine,whether the response to Dbl is mediated through Cdc42Hs or RhoA, we used the PAKR construct, since PAK65 binds Racl and Cdc42Hs but not RhoA (Manser et al., 1994; Martin et al., 1995) . Cotransfection with either Rac1(N17) or PAKR inhibited JNK activation by Dbl, but Ha-Ras(N17) had only a small effect on this response. Neither Racl(N17) nor PAKR inhibited Dbl expression, as determined by immunoblotting (data not shown). In contrast with its effect on JNK, the Dbl expression vector did not stimulate HA-ERK2 activity ( Figure 6B ).
Activation of JNKK by Racl
The activation of both JNK1 and p38 by Racl suggested that the protein kinase that can activate both of these MAPKs, SEK1/MKK4/JNKK, may mediate this response. Indeed, we found that cotransfection with the Rac1(V12) vector activated a G S T -J N K K chimera whose activity was measured by a coupled kinase assay ( Figure 7A ). While the response to Racl is weaker than the response to MEKK1, it is worth noting that MEKK1 is a direct JNKK activator whose expression appears to be rate limiting, as even a small increase in its expressiQn results in consider- . GST-JNKK was isolated from cell lysates by binding to gluthionine-Sepharose and JNKK activity was determined by a coupled kinase assay using recombinant JNK1 and GST-c-Jun (G-c J) as substrates. This experiment was repeated twice with similar results.
(B) COS-1 cells were transfected with pSRa-HA-JNK1, pCMV5-MEKK, pSRa-Rac2(L61), pSRcz-JNKK(K116R), or empty exp~'ession vectors, as indicated. JNK activity and expression were determined as described above. The levels of JNK activity are expressed relative to those seen in cells cotransfected with MEKK. Owing to higher basal levels in COS-1 cells, the fold stimulation is not as high as in HeLa or NIH 3T3 cells. (C) HeLa cells were cotransfected with HA-JNK1 and either Rac1(V12), MEKKA(K432M), or empty expression vectors, as indicated. HA-JNK1 activity was measured as described above and is expressed relative to the level found in Rac 1 (V12)-transfected cells. This experiment was repeated twice with similar results.
able JNKK or JNK activation (Lin et al., 1995; Minden et al., 1994) . Consistent with these results, we found that cotransfection with a vector encoding catalytically inactive JNKK blocked JNK activation by Rac2(L61) ( Figure 7B ). JNK activation by Rac1(V12) was also inhibited by cotransfection of a plasmid encoding catalytically inactive MEKK1 ( Figure 7C ). Rac1(N17) did not inhibit JNK activation by MEKK1 (data not shown).
Stimulation of c-Jun Transcriptional Activity by Rac and Cdc42Hs
The efficient activation of the JNK cascade by Racl/Rac2 and Cdc42Hs should result in stimulation of c-Jun transcriptional activity. Indeed, both Rac2(L61) and Cdc42Hs(V12) stimulated the transcriptional activity of a GAL4-c-Jun (1-223) fusion protein containing the c-Jun activation domain (Figure 8 ). This stimulation is likely to depend on c-Jun phosphorylation because neither Rac1(V12) nor Cdc42Hs(V12) stimulated the activity of a GAL4-c-Jun (1-223;A63/73) fusion protein in which the serines that are phosphorylated by JNK were replaced by alanines.
Discussion
Members of the Rho subfamily of small GTPases, Racl, RhoA, and Cdc42Hs, mediate effects of growth factors and polypeptide hormones on the actin cytoskeleton and thereby affect cell morphology Kozma et al., 1995; Nobes and Hall, 1995) . These functions are evolutionary conserved, as the Cdc42Sc protein is involved in bud site selection and polarized cell growth (Adams et al., 1990) . There is also circumstantial evidence that the Rho-like proteins may have additional effects on the control of cell growth and proliferation. For example, several members of the Dbl family, which may function as nucleotide exchange factors for the Rholike proteins, have oncogenic activity (Adams et al., 1992; Hart et al., 1991 Hart et al., , 1994 Miki et al., 1993) . Furthermore, activated Racl cooperates with a membrane-targeted form of Raf (Raf-CAAX) in oncogenic transformation (Qiu et al., 1995) . Although these effects could be mediated through modulation of the cytoskeleton, since oncogenic transformation and Ha-Ras activation in particular are associated with cell shape changes (Bar-Sagi and Feramisco, 1986; Ridley, 1994) , we show that the functions of Racl/Rac2 and Cdc42Hs are not limited to their effects on cell morphology. These proteins are efficient activators of a signaling cascade affecting two subgroups of MAPKs: the JNKs/SAPKs and p38/Mpk2. Interestingly, another member of this subfamily, RhoA, is incapable of activating this cascade, and none of the Rho-like proteins examined affected the ERK subgroup of MAPKs. Consistent with activation of the JNK cascade, both Racl and Cdc42Hs stimulated the transcriptional activity of c-Jun. As the'JNKs and probably p38 are likely to be capable of phosphorylating other transcription factors, as well as regulatory proteins that act posttranscriptionally , Racl/ Rac2 and Cdc42Hs may mediate effects of growth factors and polypeptide hormones on gene expression. In that respect, they are similar to members of the Ras subfamily of GTPases, whose function in linking growth factor receptor activation to transcriptional responses via MAPK activation is well established (Egan and Weinberg, 1993; Marshall, 1995; Hill and Treisman, 1995) .
The role of Racl/Rac2 and Cdc42Hs in JNK activation was established by three types of experiments. First, we demonstrated that constitutively activated Rac1(V12), Rac2(L61), and Cdc42Hs(V12) stimulate the catalytic activities of JNK1 and p38 by 10-to 60-fold in transient transfection assays in two different cell types, even when expressed at relatively low levels. Stable expression of Rac1(V12) or Cdc42Hs(V12) in a third cell type also results in efficient JNK activation, albeit of a lower magnitude than the one achieved in transient transfection experiments. This difference is not su rprising, as stably transfected cells are likely to activate feedback pathways as part of their adaptation to chronic stimulation. In addition to JNK and p38 activation, we demonstrated that Racl activates In trying to sort out the epistatic relationships between Racl/Rac2 and Cdc42Hs, we also used a dominant interfering Cdc42Hs(N 17) mutant (Kozma et al., 1995) . However, the results obtained did not allow us to draw clear conclusions. While Racl(N17) inhibited JNK activation by Cdc42Hs(V12), partial but considerable inhibition of JNK activation by Rac2(L61) was obtained by expression of Cdc42Hs(N17). In addition, this mutant may have some nonspecific effect, as it also partially inhibited JNK activation by Cdc42Hs(V12) (data not shown). Thus, while it is plausible that Cdc42Hs acts upstream of Racl and Rac2, as previously suggested based orr their morphological effects (Kozma et al., 1995; Nobes and Hall, 1995) , it is worth noting that the effect of Cdc42Hs(N17) on Rac-induced lamellipodia formation was not examined. Racl/Rac2 and Cdc42Hs may interact with a common exchange factor, thus explaining the cross inhibition. However, the exact identity of the relevant exchange factors and the biochemical details of the interactions among the Rho proteins are not clear (Nobes and Hall, 1994) . Furthermore, certain proteins like Bcr contain a Dbl domain and a GTPaseactivating domain for both Rac and Cdc42Hs (Diekmann et al., 1991) . Thus, although Cdc42Hs probably acts upstream of Rac, the Cdc42Hs(N17) mutant may titrate a protein that is an important Rac effector.
Although Racl acts downstream of Ha-Ras in the pathway leading to either lamellipodia formation (Nobes and Hall, 1995; or JNK activation, it is not known how Ras activates Rac (Nobes and Hall, 1994; Ridley, 1994) . Whereas Ha-Ras(N17) completely blocks JNK activation by EGF or v-Src, Racl(N 17) leads to only partial inhibition. Although the basis for these differences could be trivial, as Rac1 (N17) is not efficiently expressed (our unpublished data), we note that even higher doses of Racl(N 17) did not completely inhibit JNK activation by the tyrosine kinases. A more likely explanation for these and previous observations, that Ha-Ras is necessary but not sufficient for JNK activation in response to EGF or nerve growth factor (Minden et al., 1994) , is that receptor activation generates another signal that synergizes with Ras to activate the JNK cascade. In T cells, for example, activation of Ras either through TCR occupancy or phorbol esters results in modest JNK activation that is strongly potentiated following treatment with Ca 2+ ionophore or activation of the CD28 auxiliary receptor (Suet al., 1994) . By itself, Ca 2÷ ionophore or CD28 does not stimulate JNK activity. Thus, the residual level of Ras activity following Racl(N 17) expression may be sufficient to synergize with the second signal to increase JNK activity. As this synergizing signal is not produced by Ha-Ras(L61), the inhibition of its activity by Rac1(N17) is more extensive. These results also suggest that the relationships among tyrosine kinases, Ha-Ras, and Rac (and Cdc42Hs) may be more complex than a single sequential cascade. A somewhat similar situation exists in Schizosaccharomyces pombe, where the Ha-Ras homolog Rasl activates Scdl, a homolog of Cdc24Sc, the exchange factor for Cdc42Sc (Chang et al., 1994) . Both Cdc24 and Scdl contain a Dbl domain and are activated by BEM1 and Scd2, respectively (Chenevert et al., 1992; Chang et al., 1994) . BEM1 and Scd2 are homologous proteins that contain SH3 domains. In Cdc42Sc, activity is also affected by RSRI/BUD1, a Raslike protein involved in bud site selection (Bender and Pringle, 1989 ) that interacts with Cdc24 (1. Herskowitz, personal communication) . Thus, as illustrated in Figure 9 , both mammalian and yeast members of the Rho subfamily receive input from Ras-like proteins and other sources. Mammalian Cdc42 was suggested to be activated by bradykinin, which operates through a trimeric G protein-coupled receptor (Kozma et al., 1995) , and Rac was suggested to be activated by phosphatidylinositide 3-kinase in addition to Ha-Ras (Nobes and Hall, 1995) .
This similarity extends to the downstream functions of the Rho-like proteins. Mutant alleles of Rasl, Scdl, and Scd2 affect both mating and cell morphology (Chang et al., 1994) . While Rasl also activates both Byr2 and the MAPKKK that acts in the pheromone signaling cascade (Herskowitz, 1995) , it was not clear how Scdl and Scd2 (Cdc24 and Cdc42) affect mating. It was recently found that Cdc42Sc is required for activation of the pheromone cascade, most likely through direct binding to STE20 (1. Herskowitz, personal communication) . In vitro, Cdc42. GTP stimulates STE20 autocatalytic activity (A. A., unpublished data). Another potential connection between Cdc42 and MAPK activation is provided by CLA4, a novel STE20-1ike kinase required for proper budding and cytokinesis in S. cerevisiae, but not for the pheromone-responsive MAPK cascade (CvrSkova et al., 1995) . The Cla4 phenotype is rescued by growth on high salt in a manner that depends on activation of the osmotic stress MAPK module, which includes HOG1 and PBS2, suggesting a relati6nship between them (Cvr~.kova et al., 1995) . Recently, two MEKKlike MAPKKKs, SSK2 and SSK22, that activate PBS2 were identified (Maeda et al., 1995) . Both JNK1 and p38 partially complement hog1 mutants (Galcheva-Gargova et al., 1994; Han et al., 1994) , and JNKK complements pbs2 mutants (Lin et al., 1995) . Thus, these results outline a remarkable evolutionary conservation in regulation of the osmotic stress and budding pathways in yeast and JNK and the cell morphology pathways in mammals (Figure 9 ).
Once activated, Racl, Cdc42Sc, and Cdc42Hs bind and presumably activate STE20-1ike kinases. In yeast, Cdc42Sc binds and presumably activates both CLA4 (CvrEkova et al., 1995) and STE20 (1. Herskowitz, personal communication) . The identity of the STE20-1ike kinase acting in the mammalian pathway is currently unknown. Although we were able to inhibit JNK activation by expressing the regulatory domain of PAK65, we have not succeeded in constructing a constitutively activated PAK65 allele to obtain positive evidence for its involvement in this pathway. In light of the results described above, the inhibitory effect of the PAK65 regulatory domain activation is not surprising, as it is expected to titrate both Ra(~l and Cdc42Hs and therefore it does not constitute evidence for the involvement of PAK65 or other family members (M. Cobb, personal communication) in JNK activation. However, based on the yeast system, we proposed that a STE20/PAK homolog acts between Rac and MEKK.
At this point it is not clear whether the JNK and p38 cascades are involved in any of the morphological changes seen in response to Rac or Cdc42Hs activation. Most likely, JNK and p38 do not directly affect these changes because the morphological responses to Rac and Cdc42Hs are distinct while their effect on the MAPK cascades are very similar. However, it is likely that JNK and possibly p38 mediate some of the long-term effects of Racl, Cdc42Hs, and Dbl on cell growth, differentiation, and proliferation. The involvement of JNK in stimulation of AP-1 activity suggests it may be responsible for the increased invasiveness of Racl(V12)-expressing cells (Michiels et al., 1995) through induction of metalloproteinase expression.
Experimental Procedures
Cell Culture and Transfections NIH 3T3, COS-l, HeLa, and CV1 cells were cultured ~n Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bo-vine serum (FBS), 1 mM glutamate, 100 U/ml penicillin, and 100 p_g/ ml streptomycin. For transient transfection assays, HeLa, COS-l, and NIH 33-3 cells grown in 35 mm dishes were transfected using the lipofectamine (GIBCO BRL) method according to the protocol of the manufacturer, keeping total DNA at 2 ~g per plate. Cells were harvested after 48 hr. CV1 cells were transfected by calcium phosphate coprecipitation, keeping total DNA at 5 p.g per plate. Luciferase activity was assayed as described elsewhere (Lin et el., 1995) . For transformation assays, NIH 3T3 cells were cultured in DMEM supplemented with 100/0 donor calf serum (DCS). Cells in 100 mm dishes were transfected with plasmid DNA together with 20 p.g of human placental DNA (a gift from M. Symons) by calcium phosphate coprecipitation. After 24 hr, cells were kept in medium containing 5°/0 DCS. The medium was changed every 4 days, and the number of foci was determined 10-14 days later. To generate stably transfected cell lines, we transfected Rat1 fibroblasts with pCVN expression vectors containing either Rac1(V12) or Cdc42Hs(V12) alleles. Prior to transfections, cells were trypsinized, washed, and resuspended at 1.5 x 103 cells/ml in cytomix buffer containing 10 mM K2HPO#'KH2PO4 (pH 7.5), 25 mM HEPES (pH 7.6), 2 mM EGTA, 5 mM MgCI2, 2 mM ATP, and 5 mM glutathione. The cell suspensions were mixed with 10 p.g of plasmid and salmon testis DNA and electroporated at 125 I~F, 250 V. Cells were then plated in 100 mm dishes, grown for 16 hr, trypsinized, resuspended in 5 ml of high glucose DMEM supplemented with 100/o FBS, 2 mM glutarnine, 100 p.g/ml streptomycin, 100 U of penicillin, and plated at various dilutions in medium containing G418 (400 I~g/ml). G418-resistant clones were selected, and positive clones were identified by immunostaining as described elsewhere (Martin et al., 1995) . Positive clones were grown in 100 mm dishes to 70%-80% confluency, followed by serum starvation for 16 hr prior to harvesting and assaying endogenous JNK and ERK activities.
Protein Kinase Assays
To assay HA-JNK1 and HA-ERK2 activity, we collected cells from 35 mm plates transfected with the various vectors in 400 ~1 of lysis buffer 48 hr after tF~lnsfection, as described elsewhere (Minden et al., 1994) . The kinases were immunoprecipitated with anti-HA antibody, and their activities were measured using 2 pg of either GST-c-Jun(1-79) or MBP as substrates (Minden et al., 1994; Ddrijard et al., 1994) . M2-p38 activity was similarly assayed after immunoprecipitation with the antiFlag antibody (IBI/Kodak) using 2 l~g of GST-ATF2(1-254) (GST-ATF2A) as a substrate (D~rijard et el., 1995; Lin et al., 1995) . Endogenous JNK and ERK activities were also assayed by immunocomplex kinase assays after immunoprecipitation of JNKI/JNK2 with anti-JNK(247) and anti-ERK2 TR10 antibodies as described elsewhere (Minden et al., 1994) . TR10 was a gift from M. Weber. All experiments were quantitated using a phosphorimager.
Immunoblotting
Immunocomplexes or 25 I~g of whole-cell lysates were resolved by SDS-PAGE and electroblotted onto Immobilon P membranes (Millipore). After blocking, the membranes were probed with anti-HA antibody or anti.JNK monoclonal antibody 333.8 (Pharmingen) as described elsewhere (Minden et el., 1994) . Immunocomplexes were visualized using enhanced chemiluminescence detection (Amersham International).
Plaamids
Racl(N 17), RhoA(V14), and RhoA(N19) were expressed in the pEXV vector . Racl(Vf2) (Ridley et el., 1992) was su bcloned into pSRa (l'akabe et al., 1988) at the EcoRI site, Rac2(L61) was subcloned into pSRa between the EcoRI and Hindlll sites. Cdc42Hs(V12) (Kozma et al., 1995) and Dbl (Hart et aL, 1991) were expressed using pCMV and pEXV expression vectors, respectively, pSG-v-Src was a gift from T. Deng. The HA-JNK1, HA-ERK2, M2-p38, MEKKt, MEKKA(K432M), human JNKK, human JNKK(Kt 16R), JNKI(APF), GAL4-c-Jun(f-223), and GAL4-c-Jun(1-223;A63/73) expression vectors were described (D6rijard et aL, 1994; Suet el., 1994; Minden et el., 1994; Lin et el., 1995) . GST-ATF2(1-254) (GST-ATF2A) was constructed by inserting a BamHINcol fragment of pRSET-His ATF2 (AbdeI-Malek Abdel Hafiz et al., 1992) into pGEX-KG, a GST fusion protein expression vector. MKK3 expression vector was a gift from K. Guan. PAKR contains the N-terminal Rac-binding domain of human PAK65 (amino acids 1-225) (Martin et al., 1995) and was expressed using the pCDB vector.
